Approvals/TGA/EXFORGE HCT 10/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

Approved

STANDARD

EXFORGE HCT 10/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

Approval Id: 1b29101bc29a564d
Product Name: EXFORGE HCT 10/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
Artg Id: 158166
Artg Name: EXFORGE HCT 10/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2010-04-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-07462-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-07459-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1b29101bc29a564d

Type

Standard